Fourth Biennial AMD Symposium

第四届AMD双年研讨会

• 批准号: 9193821
• 负责人: Patricia Ann D'Amore
• 金额: $ 2.5万
• 依托单位: SCHEPENS EYE RESEARCH INSTITUTE
• 依托单位国家: 美国
• 财政年份: 2016
• 资助国家: 美国
• 起止时间: 2016-08-01 至 2017-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9193821
• 关键词: Address; Adverse effects; Age related macular degeneration; American; Area; Award; Basic Science; Biotechnology; Blindness; Caring; Cellular biology; Collaborations; Communication; Department chair; Developed Countries; Development; Disabled Persons; Disease; Ear; Epidemic; Eye; Fertilization; Funding; Goals; Image; Inflammation; Knowledge; Light; Lipids; Methods; Molecular; Ophthalmology; Pathogenesis; Pathology; Pharmacologic Substance; Prevalence; Published Comment; Quality of life; Research; Research Institute; Research Personnel; Retina; Retinal; Risk; Schedule; Science; Scientist; Senior Scientist; Site; Specialist; Structure of retinal pigment epithelium; Thinking; Time; Travel; Underrepresented Minority; Vision; advanced disease; aging population; base; bevacizumab; connectome; cost; demographics; design; effective therapy; experience; graduate student; insight; interest; lectures; medical schools; meetings; microbiome; multidisciplinary; novel; prevent; programs; success; symposium

Funds are requested to support The Fourth Biennial Symposium on Age-related Macular Degeneration (AMD) to be held October 20 & 21, 2016 in the Starr Center for Scientific Communications at the Schepens Eye Research Institute (SERI) – Mass. Eye and Ear (MEE). The meeting is co-organized by Drs. Patricia A. D'Amore, Director of Research at SERI, Mass Eye and Ear (MEE); Dr. Ivana Kim, a retinal specialist at MEE; Dr. Joan Miller Chief of Ophthalmology at MEE and Chair of the Department of Ophthalmology at Harvard Medical School; and, Dr. Deeba Husain, Site Director, MEE Retina Consultants. This meeting will build on the strong successes of the three previous biennial meetings that were held in September 2010, September 2012, and October 2014. AMD is the leading cause of irreversible blindness in people 50 years or older in industrialized countries. More than fifteen million Americans have AMD, and as a result of the aging population, the prevalence of AMD is expected to increase by more than 50% by the year 2020. In light of these demographics, the incomplete understanding of the pathogenesis of AMD makes this a timely and important meeting. The goal of this conference is to stimulate discussion and collaborations aimed at elucidating the mechanisms that underlie the development of AMD and, thus, to identify means to treat, cure, and ultimately prevent AMD. This meeting will be distinct from other meetings on AMD in its format, which allows significant time for discussion. An additional unique feature is the inclusion of speakers from other fields whose impact on AMD has not yet been realized. Dr. Evan Gragoudas, a leader in the field, will provide introductory comments. Dr. Robert Marcs will give the Keynote Friedman lecture on building retinal connectomes, and Dr. Robert D'Amato will deliver a summary and concluding remarks. Topics to be covered include: retinal pigment epithelial cell biology, inflammation, imaging, lipids, and new molecular methods. Travel awards will be provided to attract graduate students and fellows, with a particular emphasis on under- represented minorities and persons with disabilities.

请求提供资金，以支助第四次两年一次的 黄斑变性（AMD）将于2016年10月20日和21日在Starr Schepens眼科研究所科学交流中心 （SERI）-质量。眼睛和耳朵（眼睛）。会议由帕特里夏博士共同组织 A. D 'Amore，SERI的研究主任，Mass Eye and Ear（Mass Eye and Ear）; 金博士，一位视网膜专家，琼米勒博士，眼科主任， 和哈佛医学院眼科系主任;以及， 博士Deeba Husain，研究中心主任，视网膜顾问公司。这次会议将建立 2004年举行的前三次两年期会议取得了巨大成功， 2010年9月、2012年9月和2014年10月。AMD是领先的 工业化国家50岁或50岁以上的人不可逆失明的原因 国家超过1500万美国人患有AMD， 随着人口老龄化，AMD的患病率预计将增加超过 到2020年达到50%。根据这些人口统计数据， 了解AMD的发病机制使其成为及时和重要的 会议本次会议的目标是激发讨论和合作 旨在阐明AMD发展的基础机制， 从而确定治疗、治愈和最终预防AMD的方法。本次会议 将有别于其他会议的AMD在其格式，这使得重要的 讨论的时间。一个额外的独特功能是包括扬声器 从其他领域的影响AMD尚未实现。埃文医生 该领域的领导者格拉古达斯将提供介绍性评论。罗伯特博士 Marcs将在弗里德曼的主题演讲中讲述如何构建视网膜连接体， 罗伯特·达马托博士将作总结和总结发言。主题 包括：视网膜色素上皮细胞生物学，炎症， 成像、脂质和新的分子方法。旅行奖励将提供给 吸引研究生和研究员，特别强调在- 代表少数群体和残疾人。